A Boston investment firm and Atlanta real estate operating company have entered the D.C. health care market with an ...

Phase 3 Real Estate Partners and Bain Capital Real Estate have snagged a $484 million loan to refinance a 561,000-square-foot life sciences campus in Brisbane. The San Diego-based developer and ...

Bain Capital Life Sciences Investors, LLC, a significant stakeholder in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA), recently purchased 300,000 shares of the company's ...

Imperative Care has received a green light from the FDA for its large-bore catheter to help remove stroke-causing blood clots ...

According to the filing dated January 10, 2025, Olema entered into agreements with Bain Capital Life Sciences Opportunities IV, L.P., entities affiliated with Paradigm BioCapital International ...

According to the filing dated January 10, 2025, Olema entered into agreements with Bain Capital Life Sciences Opportunities IV, L.P., entities affiliated with Paradigm BioCapital International Fund ...

The stock has shown impressive performance with a 118% return over the past year. Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Bain Capital Life Sciences Investors, LLC, a major stakeholder in Olema ...

backed by institutional investors led by Bain Capital Life Sciences. Founded in 2010, Alkeus is developing therapies for serious diseases of the eye with high unmet need, with the purpose to ...

With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration ...

The series A round was led by Abingworth, Bain Capital Life Sciences and Venrock Healthcare Capital Partners. Boyu Capital, Lilly Asia Ventures, Braidwell and 3H Health Investment also participated.